UK – Regulatory approval of Pfizer/BioNTech vaccine for COVID-19

Information for healthcare professionals and the public about the Pfizer/BioNTech vaccine.

Par
RIS.WORLD
-
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

There are four presentations of the original COVID-19 Vaccine Pfizer/BioNTech authorised for use in Great Britain, three of which are currently available and all require dilution:

  • The 30 microgram/dose presentation (purple cap)
  • The 10 microgram/dose paediatric presentation currently for 5-11 year-olds (orange cap)
  • The 3 microgram/dose paediatric presentation currently for infants and children aged 6 months to 4 years (maroon cap)…

ARTICLES CONNEXESPLUS DE L'AUTEUR